HELM attracting attention at Bio-IT World 2015

Having won the 2014 Best Practice Award at the Bio-IT World Conference & Expo, HELM again attracted plenty of attention at this year’s meeting (Boston, April 21-23 2015). Numerous contributions gave an overview of the growing HELM ecosystem and its adoption by the pharmaceutical industry.

HELM Phase 1 Exceeded Expectations

The Pistoia Alliance HELM project started almost two years ago in December 2012 when David Klatte proposed that the Pistoia Alliance help open source a technology first developed for internal use at Pfizer. That technology was HELM and it enabled the representation of complex macromolecules. The Pistoia Alliance membership enthusiastically embraced the idea and the HELM project was born.

HELM takes on indescribable biology

HELM addresses a problem at the root level of drug discovery. Pharmaceutical and biotech companies are looking at increasingly complex molecules in the search for new therapeutics, testing out RNA- and peptide-based compounds that tap directly into cellular pathways.